FAG
MRNA icon

Fortitude Advisory Group’s Moderna MRNA Stock Holding History

Fortitude Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-225
Closed -$39K – 865
2022
Q1 		$39K Buy
225
+5
+2% +$842 0.02% 616
2021
Q4 		$56K Buy
+220
New +$64.3K 0.03% 512

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fortitude Advisory Group's MRNA Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Moderna (MRNA) in Q2 2022, closing a stake of 225 shares — an estimated $39K sold.

Fortitude Advisory Group first reported a position in MRNA in Q4 2021 and held it in 2 quarters. The position peaked at $56K in Q4 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Fortitude Advisory Group reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 225 Moderna shares in Q2 2022, an estimated $39K.
  • Fortitude Advisory Group first reported a position in Moderna in Q4 2021 and held it in 2 quarters.
  • Fortitude Advisory Group's Moderna position peaked at $56K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.